The Preparation and Evaluation of Albendazole Microspheres for Colonic Delivery

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-12-02-2004, Volume 28, Issue 11

Microspheres of Eudragit RL were developed for colonic delivery of albendazole. The effects of polymer concentration, stirring rate, and concentration of emulsifier on particle size and drug loading were studied. A comparative in vitro drug release study of the optimized formulation was carried out.

Related Content:

Drug DeliveryFormulationSolid/Semi-Solid DosageManufacturingDevelopmentDosage FormsPharmaceutical Technology-12-02-2004
FDA Rare Disease Innovation Moves Forward
Denmark’s First AI Supercomputer for Drug Discovery Now Operational Under Novo Nordisk Foundation Commitment
Lilly and ViaNautis Bio Partner on Development of Novel Therapeutics Delivering Genetic Cargo